
Meridian Bioscience VIVO
Quartalsbericht 2023-Q1
hinzugefügt 16.05.2026
Meridian Bioscience EV/EBITDA 2011-2026 | VIVO
EV/EBITDA Jährlich Meridian Bioscience
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 18.4 | 7.69 | 9.98 | 11.4 | 18.4 | 12.6 | 12.2 | 11.5 | 9.16 | 13.4 | 11.4 | 12.4 | -0.827 | -1.02 | -1.04 | - |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 18.4 | -1.04 | 9.7 |
EV/EBITDA anderer Aktien in der Diagnostik & Forschung
| Name | EV/EBITDA | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
|
Enzo Biochem
ENZ
|
2.04 | - | -8.98 % | $ 14.8 K | ||
|
Centogene N.V.
CNTG
|
0.387 | - | -6.23 % | $ 30.6 M | ||
|
Heska Corporation
HSKA
|
-134 | - | - | $ 1.31 B | ||
|
DermTech
DMTK
|
-0.68 | - | -11.32 % | $ 2.94 M | ||
|
Quest Diagnostics Incorporated
DGX
|
5.51 | $ 202.18 | -0.43 % | $ 22.4 B | ||
|
Celcuity
CELC
|
-32.4 | $ 88.24 | -0.35 % | $ 4.13 B | ||
|
Akumin
AKU
|
23.4 | - | -17.87 % | $ 25.9 M | ||
|
Co-Diagnostics
CODX
|
0.0391 | $ 3.78 | -11.89 % | $ 5.03 M | ||
|
Fulgent Genetics
FLGT
|
-8.71 | $ 18.35 | -1.77 % | $ 565 M | ||
|
Castle Biosciences
CSTL
|
-227 | $ 20.66 | -0.19 % | $ 599 M | ||
|
Aspira Women's Health
AWH
|
-1.36 | - | -6.19 % | $ 10.5 M | ||
|
Accelerate Diagnostics
AXDX
|
-2.05 | - | -61.36 % | $ 2.46 M | ||
|
Biocept
BIOC
|
-0.496 | - | -13.05 % | $ 7.29 M | ||
|
Oxford Immunotec Global PLC
OXFD
|
-73.4 | - | - | $ 562 M | ||
|
Guardant Health
GH
|
-38.2 | $ 129.82 | -1.37 % | $ 16.3 B | ||
|
Interpace Biosciences
IDXG
|
3.62 | $ 1.58 | -1.56 % | $ 6.99 M | ||
|
CareDx, Inc
CDNA
|
-100 | $ 24.08 | 4.83 % | $ 1.28 B | ||
|
Chembio Diagnostics
CEMI
|
-1.86 | - | 0.22 % | $ 16.8 M | ||
|
Check-Cap Ltd.
CHEK
|
0.000843 | - | - | $ 9.42 M | ||
|
Illumina
ILMN
|
22.1 | $ 166.89 | 3.68 % | $ 25.9 B | ||
|
ICON Public Limited Company
ICLR
|
20 | $ 147.72 | 1.05 % | $ 11.6 B | ||
|
HTG Molecular Diagnostics
HTGM
|
-0.156 | - | -20.0 % | $ 1.06 M | ||
|
Global Cord Blood Corporation
CO
|
-4.15 | - | - | $ 399 M | ||
|
Fluidigm Corporation
FLDM
|
-13.6 | - | 1.08 % | $ 308 M | ||
|
Mettler-Toledo International
MTD
|
627 | $ 1 154.47 | 2.03 % | $ 23.8 B | ||
|
Genetic Technologies Limited
GENE
|
-2.67 | - | - | $ 7.1 B | ||
|
Genetron Holdings Limited
GTH
|
-0.932 | - | 0.12 % | $ 80.1 M | ||
|
National Research Corporation
NRC
|
14.3 | $ 18.31 | -2.55 % | $ 410 M | ||
|
Natera
NTRA
|
-112 | $ 216.97 | 2.31 % | $ 29.7 B | ||
|
Lantheus Holdings
LNTH
|
15.5 | $ 104.67 | 0.14 % | $ 7.06 B | ||
|
Charles River Laboratories International
CRL
|
26.6 | $ 188.47 | 0.51 % | $ 9.34 B | ||
|
PRA Health Sciences, Inc.
PRAH
|
20.8 | - | - | $ 10.7 B | ||
|
Pacific Biosciences of California
PACB
|
-2.24 | $ 1.32 | 0.76 % | $ 396 M | ||
|
Medpace Holdings
MEDP
|
30.7 | $ 467.5 | 0.03 % | $ 13.5 B | ||
|
Exact Sciences Corporation
EXAS
|
-20.8 | - | - | $ 19.8 B | ||
|
NeoGenomics
NEO
|
-33.5 | $ 11.09 | -0.54 % | $ 1.42 B | ||
|
Myriad Genetics
MYGN
|
-1.79 | $ 4.32 | -0.23 % | $ 400 M | ||
|
Personalis
PSNL
|
-4.87 | $ 9.79 | 2.09 % | $ 874 M | ||
|
Koninklijke Philips N.V.
PHG
|
17.1 | $ 26.69 | 0.87 % | $ 25.3 B | ||
|
Senseonics Holdings
SENS
|
-5.62 | $ 7.24 | 0.84 % | $ 302 M | ||
|
QIAGEN N.V.
QGEN
|
13.2 | - | - | $ 10.6 B | ||
|
Soleno Therapeutics
SLNO
|
186 | - | - | $ 2.69 B | ||
|
Biomerica
BMRA
|
-6.24 | $ 2.0 | -2.44 % | $ 4.59 M | ||
|
Twist Bioscience Corporation
TWST
|
-23.6 | $ 80.79 | 6.07 % | $ 4.83 B | ||
|
Laboratory Corporation of America Holdings
LH
|
8.7 | $ 265.03 | -0.42 % | $ 22.1 B | ||
|
Thermo Fisher Scientific
TMO
|
19.3 | $ 473.72 | 1.03 % | $ 179 B | ||
|
Trinity Biotech plc
TRIB
|
-15.5 | $ 0.68 | 4.18 % | $ 244 M | ||
|
Motus GI Holdings
MOTS
|
-0.0496 | - | -34.28 % | $ 263 K | ||
|
Neogen Corporation
NEOG
|
40.3 | $ 9.3 | 2.2 % | $ 2.02 B | ||
|
Invitae Corporation
NVTA
|
44.6 | - | - | $ 21.2 M |